BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32636772)

  • 1. DNA Methylation of the t-PA Gene Differs Between Various Immune Cell Subtypes Isolated From Depressed Patients Receiving Electroconvulsive Therapy.
    Moschny N; Jahn K; Bajbouj M; Maier HB; Ballmaier M; Khan AQ; Pollak C; Bleich S; Frieling H; Neyazi A
    Front Psychiatry; 2020; 11():571. PubMed ID: 32636772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel candidate genes for ECT response prediction-a pilot study analyzing the DNA methylome of depressed patients receiving electroconvulsive therapy.
    Moschny N; Zindler T; Jahn K; Dorda M; Davenport CF; Wiehlmann L; Maier HB; Eberle F; Bleich S; Neyazi A; Frieling H
    Clin Epigenetics; 2020 Jul; 12(1):114. PubMed ID: 32727556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroconvulsive therapy, changes in immune cell ratios, and their association with seizure quality and clinical outcome in depressed patients.
    Moschny N; Jahn K; Maier HB; Khan AQ; Ballmaier M; Liepach K; Sack M; Skripuletz T; Bleich S; Frieling H; Neyazi A
    Eur Neuropsychopharmacol; 2020 Jul; 36():18-28. PubMed ID: 32446707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study.
    Okamoto T; Yoshimura R; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Inoue Y; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1185-90. PubMed ID: 18403081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF).
    Freire TF; Fleck MP; da Rocha NS
    Brain Res Bull; 2016 Mar; 121():263-9. PubMed ID: 26892396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy.
    Kleimann A; Kotsiari A; Sperling W; Gröschl M; Heberlein A; Kahl KG; Hillemacher T; Bleich S; Kornhuber J; Frieling H
    J Neural Transm (Vienna); 2015 Jun; 122(6):925-8. PubMed ID: 25387785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy.
    Neyazi A; Theilmann W; Brandt C; Rantamäki T; Matsui N; Rhein M; Kornhuber J; Bajbouj M; Sperling W; Bleich S; Frieling H; Löscher W
    Transl Psychiatry; 2018 Jan; 8(1):25. PubMed ID: 29353887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Mature BDNF Level Is Associated with Remission Following ECT in Treatment-Resistant Depression.
    Psomiades M; Mondino M; Galvão F; Mandairon N; Nourredine M; Suaud-Chagny MF; Brunelin J
    Brain Sci; 2022 Jan; 12(2):. PubMed ID: 35203890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a right unilateral ultrabrief pulse electroconvulsive therapy course on health related quality of life in elderly depressed patients.
    McCall WV; Lisanby SH; Rosenquist PB; Dooley M; Husain MM; Knapp RG; Petrides G; Rudorfer MV; Young RC; McClintock SM; Mueller M; Prudic J; Greenberg RM; Weiner RD; Bailine SH; Riley MA; McCloud L; Kellner CH;
    J Affect Disord; 2017 Feb; 209():39-45. PubMed ID: 27886569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy.
    Piccinni A; Del Debbio A; Medda P; Bianchi C; Roncaglia I; Veltri A; Zanello S; Massimetti E; Origlia N; Domenici L; Marazziti D; Dell'Osso L
    Eur Neuropsychopharmacol; 2009 May; 19(5):349-55. PubMed ID: 19223156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients.
    Maffioletti E; Gennarelli M; Gainelli G; Bocchio-Chiavetto L; Bortolomasi M; Minelli A
    J ECT; 2019 Sep; 35(3):189-194. PubMed ID: 30994478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder.
    Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2016 May; 76():1-8. PubMed ID: 26859236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression.
    Gedge L; Beaudoin A; Lazowski L; du Toit R; Jokic R; Milev R
    Front Psychiatry; 2012; 3():12. PubMed ID: 22375129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder.
    Sorri A; Järventausta K; Kampman O; Lehtimäki K; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E
    Brain Behav; 2018 Nov; 8(11):e01101. PubMed ID: 30273985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with major depressive disorder: A systematic review and meta-analysis.
    Luan S; Zhou B; Wu Q; Wan H; Li H
    Asian J Psychiatr; 2020 Jun; 51():101983. PubMed ID: 32146142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electroconvulsive therapy response in major depressive disorder: a pilot functional network connectivity resting state FMRI investigation.
    Abbott CC; Lemke NT; Gopal S; Thoma RJ; Bustillo J; Calhoun VD; Turner JA
    Front Psychiatry; 2013; 4():10. PubMed ID: 23459749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroconvulsive Therapy Modulates Loudness Dependence of Auditory Evoked Potentials: A Pilot MEG Study.
    Dib M; Lewine JD; Abbott CC; Deng ZD
    medRxiv; 2024 Apr; ():. PubMed ID: 38903065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton magnetic resonance spectroscopic analysis of changes in brain metabolites following electroconvulsive therapy in patients with major depressive disorder.
    Tosun Ş; Tosun M; Akansel G; Gökbakan AM; Ünver H; Tural Ü
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):96-101. PubMed ID: 31825726
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression.
    Vanicek T; Kranz GS; Vyssoki B; Fugger G; Komorowski A; Höflich A; Saumer G; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
    Brain Stimul; 2019; 12(4):1041-1050. PubMed ID: 31000384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of Action of ECT in Depression.
    Belge JB; van Eijndhoven P; Mulders PCR
    Curr Top Behav Neurosci; 2023 Nov; ():. PubMed ID: 37962811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.